MAPT and Cognitive impairment: Interestingly, diosmin reduced cerebral Aβ oligomers, tau hyperphosphorylation, and cognitive impairment by increasing transient receptor potential canonical 6 (TRPC6) and reducing interferone-γ (IFNγ) and pro-inflammatory cytokines (TNFα and IL-12) in a dose-dependent manner.